Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus (Q38827301)

6 September 2017

Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus (English)

1 reference

6 September 2017

Orthoebolavirus zairense

0 references

author

Júlia Vergara-Alert

9

1 reference

6 September 2017

1

Verena Krähling

1 reference

6 September 2017

10

Stephan Becker

1 reference

6 September 2017

4

Markus Eickmann

1 reference

6 September 2017

Dirk Becker

2

1 reference

6 September 2017

Cornelius Rohde

3

1 reference

6 September 2017

Yonca Eroğlu

5

1 reference

6 September 2017

Astrid Herwig

6

1 reference

6 September 2017

Romy Kerber

7

1 reference

6 September 2017

Katharina Kowalski

8

1 reference

6 September 2017

European Mobile Laboratory consortium

11

1 reference

6 September 2017

16 October 2015

1 reference

Medical Microbiology and Immunology

6 September 2017

1 reference

6 September 2017

205

1 reference

6 September 2017

173-183

1 reference

6 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00430-015-0438-6

6 September 2017

0 references

cites work

Filoviridae: a taxonomic home for Marburg and Ebola viruses?

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Pathogenesis of filoviral haemorrhagic fevers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Ebola vaccine--an urgent international priority

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Nucleoprotein-based indirect enzyme-linked immunosorbent assay (indirect ELISA) for detecting antibodies specific to Ebola virus and Marbug virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

ELISA for the detection of antibodies to Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Emergence of Zaire Ebola Virus Disease in Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

A case of severe Ebola virus infection complicated by gram-negative septicemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Phosphorylation of Marburg virus matrix protein VP40 triggers assembly of nucleocapsids with the viral envelope at the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooué-Ivindo region, Northeastern Gabon, 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0438-6

Immunoglobulin G enzyme-linked immunosorbent assay using truncated nucleoproteins of Reston Ebola virus

21 January 2018

1 reference

12 December 2020

Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report

1 reference

12 December 2020

Refolding of an integral membrane protein. OmpA of Escherichia coli

1 reference

12 December 2020

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

1 reference

12 December 2020

IgY technology: extraction of chicken antibodies from egg yolk by polyethylene glycol (PEG) precipitation

1 reference

12 December 2020

Molecular biology and evolution of filoviruses.

1 reference

12 December 2020

Validation of serological assays for diagnosis of infectious diseases

1 reference

12 December 2020

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

1 reference

12 December 2020

10.1007/S00430-015-0438-6

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1041010957

0 references

Fatcat ID

release_buedfecourd77i2g5zllsqx2ue

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/buedfecourd77i2g5zllsqx2ue

24 November 2022

mapped directly with Wikidata item

1 reference